Venous thromboembolism risk and antithrombotic prophylaxis among patients admitted to Spanish hospitals (ENDORSE study);Original riesgo de enfermedad tromboembólica venosa y profilaxis antitrombótica en los pacientes ingresados en hospitales españoles (estudio ENDORSE)

Medicina Clinica

Volumn 133, Issue 1, 2009, Pages 1-7

  Rodríguez, José Antonio Nieto ^a  

^a HOSPITAL VIRGEN DE LA LUZ   (Spain)

Author keywords

Prophylaxis guides; Thromboembolism; Venous thromboembolic disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; COMPRESSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RISK ASSESSMENT; SPAIN; SURGICAL WARD; THROMBOSIS PREVENTION; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; HOSPITALIZATION; MULTICENTER STUDY; RISK FACTOR;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; MALE; RISK FACTORS; SPAIN; VENOUS THROMBOEMBOLISM;

EID: 67650066409     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.01.040     Document Type: Article

References (30)

1. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, VTE Impact Assessment Group in Europe (VITAE), et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756-64.
2. Linblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991;302:709-11.
3. Grupo Multidisciplinar para el Estudio de la Enfermedad Tromboembólica en España. Estudio sobre la enfermedad tromboembólica en España [consultado 26/6/2008]. 2006. Disponible en: URL: www.fesemi.org/grupos/e-tromboembolica/publicaciones/index.php.
4. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis?. J Roy Soc Med. 1989;82:203-5.
5. Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalised patients: A necropsy review. J Clin Pathol. 2004;57:1254-7.
6. Goldhaber SZ. Venous thromboembolism risk among hospitalised patients: Magnitude of the risk is staggering. Am J Hematol. 2007;82:775-6.
7. Prandoni P, Lensing AWA, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term course of acute deep venous thrombosis. Ann Intern Med. 1996; 125:1-7.
8. Pengo V, Lensing AW, Prins MH, Marchioni A, Davidson BL, Tiozzo F, Thromboembolic Pulmonary Hypertension Study Group, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-64.
9. Rodríguez A, Vallano A. Profilaxis de la tromboembolia venosa en pacientes con procesos médicos agudos. Med Clin (Barc). 2006;126:754-6.
10. Clagett GP, Anderson Jr FA, Levine MN, Salzman EW, Wheeler HB. Prevention of venous thromboembolism. Chest. 1992;102 (4 suppl) :391S-407S.
11. Villar Fernández I, Urbieta Sanz E, Arenere Mendoza M, López Larramona G, Marcilla Córdoba F, Rabanaque Hernández MJ. Assessing the use of low-molecular-weight heparins for venous thromboembolism prophylaxis in internal medicine patients. Farm Hosp. 2005;29:69-70.
12. Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalised medical patients: Findings from the International Medical Prevention registry on Venous Thromboembolism. Chest. 2007;132:936-45.
13. Otero R, Uresandi F, Cayuela A, Blanquer J, Cabezudo MA, De Gregorio MA, et al. Use of venous thromboembolism prophylaxis for surgical patients: A multi-center analysis of practice in Spain. Eur J Surg. 2001;167:163-7.
14. Rashid ST, Thursz, Razvi NA, Voller R, Orchard T, Rashid ST, et al. Venous thromboprophylaxis in UK medical inpatients. J R Soc Med. 2005;98: 507-12.
15. Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119:145-55.
16. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007;64:69-76.
17. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study) : A multinational cross-sectional study. Lancet. 2008;371:387-94.
18. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126 (3 suppl) :338S-400S.
19. The European Hospital Register [acceso 10ct 2007]. Disponible en: URL: http://www.europeanhospitalregister.com
20. Baglin T, Barrowcliffe TW, Cohen A, Greaves M, British Committee for Standards in Haematology. Guidelines on the use and monitoring of heparin. Br J Haematol. 2006;133:19-34.
21. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet 1975; 2:45-51.
22. Labarere J, Bosson JL, Sevestre MA, Delmas AS, Dupas S, Thenault MH, et al. Brief report: Graduated compression stocking thromboprophylaxis for elderly inpatients: A propensity analysis. J Gen Intern Med. 2006;21:1282-7.
23. Monreal M, Kakkar AK, Caprini JA, Barba R, Uresandi F, Valle R, et al. The outcome after treatment of venous thromboembolism is different in surgical and in acute ill medical patients. Findings from the RIETE registry. J Thromb Haemost. 2004;2:1892-8.
24. Vallano A, Arnau JM, Miralda GP, Pérez Bartoli J. Use of venous thrombopro-phylaxis and adherence to guideline recommendations: A cross-sectional study. Thromb J. 2004;2:3.
25. Sprigg N, Gray LJ, Bath PM, Boysen G, Paul De Deyn P, Leys D, et al. Compression stockings and the prevention of symptomatic venous throm-boembolism: Data from the Tinzaparin in Acute Ischemic Stroke Trial. J Stroke Cerebrovasc Dis. 2005;14:203-9.
26. Burleigh E, Wang C, Foster D, Heller S, Dunn D, Safavi K, et al. Thrombopro-phylaxis in medically ill patients at risk for venous thromboembolism. Am J Health Syst Pharm. 2006;63:S23-9.
27. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: Success or failure?. J Thromb Haemost. 2007;5:1610.
28. Sellier E, Labarere J, Bosson JL, Auvray M, Barrellier MT, Le Hello C, et al. Effectiveness of a guideline for venous thromboembolism prophylaxis in elderly post-acute care patients: A multicenter study with systematic ultrasonographic examination. Arch Intern Med. 2006;166:2065-71.
29. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352:969-77.
30. Lecumberri R, Marqués M, Díaz-Navarlaz MT, Panizo E, Toledo J, García-Mouriz A, et al. Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalised patients. Thromb Haemost. 2008;100:669-704.